The stock price of Baird Medical Investment Holdings Limited (NASDAQ: BDMD) has jumped by 63.28 compared to previous close of 5.42. Despite this, the company has seen a fall of -0.11% in its stock price over the last five trading days. prnewswire.com reported 2025-01-17 that NEW YORK, Jan. 17, 2025 /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in San Francisco amid the 2025 J.P.
Is It Worth Investing in Baird Medical Investment Holdings Limited (NASDAQ: BDMD) Right Now?
Additionally, the 36-month beta value for BDMD is -0.69.
The average trading volume of BDMD on January 20, 2025 was 1.68M shares.
BDMD’s Market Performance
BDMD’s stock has seen a -0.11% decrease for the week, with a 456.60% rise in the past month and a 171.47% gain in the past quarter. The volatility ratio for the week is 57.40%, and the volatility levels for the past 30 days are at 63.53% for Baird Medical Investment Holdings Limited. The simple moving average for the past 20 days is 71.35% for BDMD’s stock, with a 8.68% simple moving average for the past 200 days.
BDMD Trading at 156.88% from the 50-Day Moving Average
After a stumble in the market that brought BDMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.54% of loss for the given period.
Volatility was left at 63.53%, however, over the last 30 days, the volatility rate increased by 57.40%, as shares surge +486.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +221.82% upper at present.
During the last 5 trading sessions, BDMD fell by -0.11%, in comparison to the 20-day moving average, which settled at $5.16. In addition, Baird Medical Investment Holdings Limited saw 16.45% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BDMD
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.87 for the gross margin
The net margin for Baird Medical Investment Holdings Limited stands at 0.15. The total capital return value is set at 0.05. Equity return is now at value -25.39, with -14.19 for asset returns.
Based on Baird Medical Investment Holdings Limited (BDMD), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.31.
Currently, EBITDA for the company is 12.85 million with net debt to EBITDA at 4.04. When we switch over and look at the enterprise to sales, we see a ratio of 24.95. The receivables turnover for the company is 0.38for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.
Conclusion
In conclusion, Baird Medical Investment Holdings Limited (BDMD) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.